Long-axial field-of-view PET/CT for the assessment of inflammation in calcified coronary artery plaques with [<sup>68</sup> Ga]Ga-DOTA-TOC.
Journal Information
Full Title: Eur J Nucl Med Mol Imaging
Abbreviation: Eur J Nucl Med Mol Imaging
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Nuclear Medicine
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethical approvalThe cantonal ethics committee approved this patient acquisition (KEK-Nr. 2022–00486). All patients provided written informed consent for inclusion. The study was performed in accordance with the Declaration of Helsinki. Conflict of interestAR has received research support and speaker honoraria from Siemens. All other authors have no conflicts of interest to report. CG received funding from the Swiss National Science Foundation, InnoSuisse, CAIM foundation and GAMBIT foundation, outside of the submitted work. LN is principal investigator of a service agreement with United Imaging Healthcare. UC Davis has a revenue-aharing agreement with United Imaging Healthcare that is based on uEXPLORER sales. LN is site PI of clinical trials supported by Novartis Pharmaceuticals Corporation. LN is PI of clinical trials supported by Telix PHarmaceuticals, Lantheus Medical Imaging and GE Healthcare. LN is Co-I of a clinical trial supported by Lilly. Conflict of interest AR has received research support and speaker honoraria from Siemens. All other authors have no conflicts of interest to report. CG received funding from the Swiss National Science Foundation, InnoSuisse, CAIM foundation and GAMBIT foundation, outside of the submitted work. LN is principal investigator of a service agreement with United Imaging Healthcare. UC Davis has a revenue-aharing agreement with United Imaging Healthcare that is based on uEXPLORER sales. LN is site PI of clinical trials supported by Novartis Pharmaceuticals Corporation. LN is PI of clinical trials supported by Telix PHarmaceuticals, Lantheus Medical Imaging and GE Healthcare. LN is Co-I of a clinical trial supported by Lilly. "
"Funding Open access funding provided by University of Bern"
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025